257 related articles for article (PubMed ID: 34743782)
21. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
22. Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer.
Lu CS; Shiau AL; Su BH; Hsu TS; Wang CT; Su YC; Tsai MS; Feng YH; Tseng YL; Yen YT; Wu CL; Shieh GS
J Hematol Oncol; 2020 Jun; 13(1):62. PubMed ID: 32487125
[TBL] [Abstract][Full Text] [Related]
23. STAT3/NF-κB signalling disruption in M2 tumour-associated macrophages is a major target of PLGA nanocarriers/PD-L1 antibody immunomodulatory therapy in breast cancer.
Cavalcante RS; Ishikawa U; Silva ES; Silva-Júnior AA; Araújo AA; Cruz LJ; Chan AB; de Araújo Júnior RF
Br J Pharmacol; 2021 Jun; 178(11):2284-2304. PubMed ID: 33434950
[TBL] [Abstract][Full Text] [Related]
24. Tumor-associated macrophage derived IL-6 enriches cancer stem cell population and promotes breast tumor progression via Stat-3 pathway.
Radharani NNV; Yadav AS; Nimma R; Kumar TVS; Bulbule A; Chanukuppa V; Kumar D; Patnaik S; Rapole S; Kundu GC
Cancer Cell Int; 2022 Mar; 22(1):122. PubMed ID: 35300689
[TBL] [Abstract][Full Text] [Related]
25. Antitumor properties of triptolide: phenotype regulation of macrophage differentiation.
Li H; Li L; Mei H; Pan G; Wang X; Huang X; Wang T; Jiang Z; Zhang L; Sun L
Cancer Biol Ther; 2020; 21(2):178-188. PubMed ID: 31663424
[TBL] [Abstract][Full Text] [Related]
26. Oral Squamous Cell Carcinoma Contributes to Differentiation of Monocyte-Derived Tumor-Associated Macrophages via PAI-1 and IL-8 Production.
Kai K; Moriyama M; Haque ASMR; Hattori T; Chinju A; Hu C; Kubota K; Miyahara Y; Kakizoe-Ishiguro N; Kawano S; Nakamura S
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502382
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer cells promote CD169
Jing W; Guo X; Wang G; Bi Y; Han L; Zhu Q; Qiu C; Tanaka M; Zhao Y
Int Immunopharmacol; 2020 Jan; 78():106012. PubMed ID: 31865052
[TBL] [Abstract][Full Text] [Related]
28. Breast cancer cell debris diminishes therapeutic efficacy through heme oxygenase-1-mediated inactivation of M1-like tumor-associated macrophages.
Kim SH; Saeidi S; Zhong X; Gwak SY; Muna IA; Park SA; Kim SH; Na HK; Joe Y; Chung HT; Kim KE; Han W; Surh YJ
Neoplasia; 2020 Nov; 22(11):606-616. PubMed ID: 33039895
[TBL] [Abstract][Full Text] [Related]
29. Dimethyl Sulfoxide Suppresses Mouse 4T1 Breast Cancer Growth by Modulating Tumor-Associated Macrophage Differentiation.
Deng R; Wang SM; Yin T; Ye TH; Shen GB; Li L; Zhao JY; Sang YX; Duan XG; Wei YQ
J Breast Cancer; 2014 Mar; 17(1):25-32. PubMed ID: 24744794
[TBL] [Abstract][Full Text] [Related]
30. PTEN inhibits macrophage polarization from M1 to M2 through CCL2 and VEGF-A reduction and NHERF-1 synergism.
Li N; Qin J; Lan L; Zhang H; Liu F; Wu Z; Ni H; Wang Y
Cancer Biol Ther; 2015; 16(2):297-306. PubMed ID: 25756512
[TBL] [Abstract][Full Text] [Related]
31. Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer.
Esser AK; Ross MH; Fontana F; Su X; Gabay A; Fox GC; Xu Y; Xiang J; Schmieder AH; Yang X; Cui G; Scott M; Achilefu S; Chauhan J; Fletcher S; Lanza GM; Weilbaecher KN
Theranostics; 2020; 10(17):7510-7526. PubMed ID: 32685002
[TBL] [Abstract][Full Text] [Related]
32. Human breast cancer cells educate macrophages toward the M2 activation status.
Sousa S; Brion R; Lintunen M; Kronqvist P; Sandholm J; Mönkkönen J; Kellokumpu-Lehtinen PL; Lauttia S; Tynninen O; Joensuu H; Heymann D; Määttä JA
Breast Cancer Res; 2015 Aug; 17(1):101. PubMed ID: 26243145
[TBL] [Abstract][Full Text] [Related]
33. M2 polarization of tumor-associated macrophages is dependent on integrin β3 via peroxisome proliferator-activated receptor-γ up-regulation in breast cancer.
Shu Y; Qin M; Song Y; Tang Q; Huang Y; Shen P; Lu Y
Immunology; 2020 Aug; 160(4):345-356. PubMed ID: 32311768
[TBL] [Abstract][Full Text] [Related]
34. Expression profile of the N-myc Downstream Regulated Gene 2 (NDRG2) in human cancers with focus on breast cancer.
Lorentzen A; Lewinsky RH; Bornholdt J; Vogel LK; Mitchelmore C
BMC Cancer; 2011 Jan; 11():14. PubMed ID: 21226903
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of endothelial cell proliferation and tumor angiogenesis by up-regulating NDRG2 expression in breast cancer cells.
Ma J; Liu W; Yan X; Wang Q; Zhao Q; Xue Y; Ren H; Wu L; Cheng Y; Li S; Miao L; Yao L; Zhang J
PLoS One; 2012; 7(2):e32368. PubMed ID: 22393400
[TBL] [Abstract][Full Text] [Related]
36. Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer.
Li D; Ji H; Niu X; Yin L; Wang Y; Gu Y; Wang J; Zhou X; Zhang H; Zhang Q
Cancer Sci; 2020 Jan; 111(1):47-58. PubMed ID: 31710162
[TBL] [Abstract][Full Text] [Related]
37. Resveratrol enhanced chemosensitivity by reversing macrophage polarization in breast cancer.
Cheuk IW; Chen J; Siu M; Ho JC; Lam SS; Shin VY; Kwong A
Clin Transl Oncol; 2022 May; 24(5):854-863. PubMed ID: 34859370
[TBL] [Abstract][Full Text] [Related]
38. Combined MEK inhibition and tumor-associated macrophages depletion suppresses tumor growth in a triple-negative breast cancer mouse model.
Zhang Q; Le K; Xu M; Zhou J; Xiao Y; Yang W; Jiang Y; Xi Z; Huang T
Int Immunopharmacol; 2019 Nov; 76():105864. PubMed ID: 31480004
[TBL] [Abstract][Full Text] [Related]
39. Cancer Cell-Derived Granulocyte-Macrophage Colony-Stimulating Factor Is Dispensable for the Progression of 4T1 Murine Breast Cancer.
Yoshimura T; Nakamura K; Li C; Fujisawa M; Shiina T; Imamura M; Li T; Mukaida N; Matsukawa A
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31888216
[TBL] [Abstract][Full Text] [Related]
40. NDRG2 Expression in Breast Cancer Cells Downregulates PD-L1 Expression and Restores T Cell Proliferation in Tumor-Coculture.
Lee A; Lim S; Oh J; Lim J; Yang Y; Lee MS; Lim JS
Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
